Multimodality endoscopic eradication for neoplastic Barrett oesophagus: Results of an European multicentre study (EURO-II)

Gut

Volumn 65, Issue 4, 2016, Pages 555-562

  Phoa, K Nadine ^a   Pouw, Roos E ^a   Bisschops, Raf ^b   Pech, Oliver ^c   Ragunath, Krish ^d   Weusten, Bas L A M ^e   Schumacher, Brigitte ^f   Rembacken, Bjorn ^g   Meining, Alexander ^h   Messmann, Helmut ⁱ   Schoon, Erik J ^j   Gossner, Liebwin ^k   Mannath, Jayan ^d   Seldenrijk, C A ^e   Visser, Mike ^a   Lerut, Toni ^b   Seewald, Stefan ^l   Ten Kate, Fiebo J ^a   Ell, Christian ^c   Neuhaus, Horst ^f   Bergman, Jacques J G H M ^a   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e ST ANTONIUS HOSPITAL   (Netherlands)

^f Children s Hospital   (Germany)

^g LEEDS GENERAL INFIRMARY   (United Kingdom)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ KLINIKUM AUGSBURG   (Germany)

^j CATHARINA HOSPITAL   (Netherlands)

^k Hospital Karlsruhe   (Germany)

^l UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; ENDOSCOPIC SURGERY; ESOPHAGUS STENOSIS; FAINTNESS; FEMALE; FEVER; FOLLOW UP; HEMATEMESIS; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LACERATION; MAJOR CLINICAL STUDY; MALE; MELENA; MULTICENTER STUDY; NEOPLASTIC BARRETT ESOPHAGUS; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE; ADOLESCENT; BIOPSY; CATHETER ABLATION; CLINICAL TRIAL; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; EUROPE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PRECANCEROUS CONDITIONS; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; CATHETER ABLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84929600616     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309298     Document Type: Article

References (42)

1. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-6.
2. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009;373:850-61.
3. Spechler SJ, Sharma P, Souza R.F., et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011;140:1084-91.
4. Pech O, Behrens A, May A., et al. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut 2008;57:1200-6.
5. Bollschweiler E, Baldus SE, Schröder W, et al. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006;38:149-56.
6. Alvarez Herrero L, Pouw RE, van Vilsteren FG, et al. Risk of lymph node metastasis associated with deeper invasion by early adenocarcinoma of the esophagus and cardia: study based on endoscopic resection specimens. Endoscopy 2010;42:1030-6.
7. Peters FP, Kara MA, Rosmolen W.D., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005;61:506-14.
8. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol 2012;107:850-62; quiz 863.
9. Bennett C, Vakil N, Bergman J., et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012;143:336-46.
10. Ell C, May A, Pech O., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007;65:3-10.
11. May A, Gossner L, Pech O., et al. Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach. Eur J Gastroenterol Hepatol 2002;14:1085-91.
12. Van Vilsteren FGI, Pouw RE, Seewald S, et al. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial. Gut 2011;60:765-73.
13. Gondrie JJ, Pouw RE, Sondermeijer CMT, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008;40:370-9.
14. Gondrie JJ, Pouw RE, Sondermeijer CMT, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008;40:359-69.
15. Pouw RE, Wirths K, Eisendrath P., et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia. Clin Gastroenterol Hepatol 2010;8:23-9.
16. Kim HP, Bulsiewicz WJ, Cotton C.C., et al. Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia. Gastrointest Endosc 2012;76:733-9.
17. Okoro NI, Tomizawa Y, Dunagan K.T., et al. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett's esophagus. Clin Gastroenterol Hepatol 2012;10:150-4.
18. Gupta M, Iyer PG, Lutzke L, et al. Recurrence of Esophageal Intestinal Metaplasia After Endoscopic Mucosal Resection and Radiofrequency Ablation of Barrett's Esophagus: Results From a US Multicenter Consortium. Gastroenterology 2013;145:79-86.e1.
19. Haidry RJ, Dunn JM, Butt M.A., et al. Radiofrequency Ablation (RFA) and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of UK National Halo RFA Registry. Gastroenterology 2013;145:87-95.
20. Pouw RE, Seewald S, Gondrie J.J., et al. Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients. Gut 2010;59:1169-77.
21. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446-54.
22. Bosman FT, Carneiro F, Hruban R.H., et al., eds. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2010.
23. Shaheen NJ, Sharma P, Overholt B.F., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009;360:2277-88.
24. Fleischer DE, Overholt BF, Sharma V.K., et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008;68:867-76.
25. Lyday WD, Corbett FS, Kuperman D.A., et al. Radiofrequency ablation of Barrett's esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy 2010;42:272-8.
26. Fleischer DE, Overholt BF, Sharma V.K., et al. Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy 2010;42:781-9.
27. Sharma V, Kim H, Das A., et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008;40:380-7.
28. Shaheen NJ, Overholt BF, Sampliner R.E., et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011;141:460-8.
29. Phoa KN, Pouw RE, van Vilsteren FGI, et al. Remission of Barrett's esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology 2013;145:96-104.
30. Weston AP, Sharma P, Banerjee S., et al. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc 2005;61:515-21.
31. Sampliner RE, Camargo E, Prasad AR. Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. Dis Esophagus 2006;19:277-9.
32. Sharma P, Morales TG, Sampliner RE. Short segment Barrett's esophagus-the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol 1998;93:1033-6.
33. Morales TG, Camargo E, Bhattacharyya A., et al. Long-term follow-up of intestinal metaplasia of the gastric cardia. Am J Gastroenterol 2000;95:1677-80.
34. Goldblum JR, Vicari JJ, Falk G.W., et al. Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology 1998;114:633-9.
35. Overholt BF, Panjehpour M, Halberg DL. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003;58:183-8.
36. Peters F, Kara M, Rosmolen W., et al. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in Barrett esophagus after endoscopic resection. Endoscopy 2005;37:418-24.
37. Gray NA, Odze RD, Spechler SJ. Buried metaplasia after endoscopic ablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011;106:1899-908; quiz 1909.
38. Pouw RE, Gondrie JJ, Rygiel A.M., et al. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia. Am J Gastroenterol 2009;104:1366-73.
39. Overholt BF, Dean PJ, Galanko J.A., et al. Does ablative therapy for Barrett esophagus affect the depth of subsequent esophageal biopsy as compared with controls? J Clin Gastroenterol 2010;44:676-81.
40. Shaheen NJ, Peery AF, Overholt B.F., et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointest Endosc 2010;72:490-6.e1.
41. van Vilsteren FG, Alvarez Herrero L, Pouw RE, et al. Radiofrequency ablation and endoscopic resection in a single session for Barrett's esophagus containing early neoplasia: a feasibility study. Endoscopy 2012;44:1096-104.
42. Manner H, Rabenstein T, Pech O., et al. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study). Endoscopy 2014;46:6-12.